Not a provider? Visit Bedsider

Birth Control

Evidence-based resources on contraceptive methods, guidelines, and best practices

Showing 58-65 of 159 results
Research Roundup

Research roundup: 2023 highlights

Highlighting one notable research article from each Research Roundup in 2023.
Birth Control

Can EC pills be used multiple times in the same cycle?

Answers for providers to the most frequently asked questions about repeated EC doses.
Research Roundup

Research roundup: November 2023 edition

Pain management during procedural abortion, serum etonogestrel levels not associated with mood changes during implant use, and clinical considerations when patients are traveling for abortion care.
Research Roundup

Research roundup: October 2023 edition

Pain management in abortion care, risk of Rh sensitization with abortion before 12 weeks’ gestation, and contraception information on TikTok.
Research Roundup

Research roundup: September 2023 edition

Patients' preferences for contraceptive educational materials, management of missing IUD strings and migrated IUDs, and providers’ perspectives on how to improve contraceptive counseling.
Research Roundup

Research roundup: August 2023 edition

COX-2 inhibitor demonstrates potential in increasing efficacy of OTC LNG-EC pills; updated systematic review and meta-analysis supporting the effectiveness and safety of misoprostol-alone for medication abortion; support needs of adolescents and young adult abortion seekers; and more!
Birth Control

Talking about OTC EC’s new label

What providers need to know about the December 2022 updates to levonorgestrel emergency contraception (LNG-EC) labeling.
Research Roundup

Research roundup: July 2023 edition

Continued support for misoprostol-only regimens for medication abortion and self-managed abortion between nine and 16 weeks gestation, the use of home pregnancy tests for follow-up care after a telehealth medication abortion, where adolescents and young adults go online to get abortion information, and disparities in recommended retesting for women with trichomonas vaginalis infections.